Deafness-vitiligo-achalasia syndrome

Deafness-vitiligo-achalasia syndrome is an extremely rare genetic disorder characterized by the triad of sensorineural hearing loss (deafness), vitiligo (patchy loss of skin pigmentation), and achalasia (a motility disorder of the esophagus in which the lower esophageal sphincter fails to relax properly, causing difficulty swallowing). This condition affects multiple body systems, including the auditory system, the integumentary system (skin), and the gastrointestinal tract. The combination of these three features suggests an underlying defect that may involve neural crest-derived cells or autoimmune-mediated processes, as melanocytes, certain components of the inner ear, and enteric neurons share developmental origins. The hearing loss is typically sensorineural in nature and may be progressive. Vitiligo presents as depigmented patches of skin due to loss of melanocytes. Achalasia leads to dysphagia (difficulty swallowing), regurgitation, and potentially weight loss or nutritional complications. Additional features such as short stature and muscle wasting have been reported in some cases. Due to the extreme rarity of this syndrome, only a handful of cases have been described in the medical literature. Treatment is symptomatic and supportive: hearing aids or cochlear implants may be used for hearing loss, dermatological management for vitiligo, and pneumatic dilation or surgical myotomy (such as Heller myotomy) for achalasia. No curative therapy is currently available.

Common questions about Deafness-vitiligo-achalasia syndrome